Качественная клиническая практика (Sep 2020)

The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders

  • O. O. Kirilochev,
  • A. R. Umerova

DOI
https://doi.org/10.37489/2588-0519-2020-3-85-92
Journal volume & issue
Vol. 0, no. 3
pp. 85 – 92

Abstract

Read online

Actuality. Drug safety issues in patients with psychiatric disorders are relevant due to specifics of clinical pharmacology of the medicinal products used, possible treatment-resistance of mental illnesses and concomitant use of multiple antipsychotic drugs. One of the aspects of treatment safety is a prediction of drug-drug interactions.The aim of the study was to analyze potential drug-drug interactions in patients with psychiatric disorders.Materials and methods. The study enrolled 500 patients with psychiatric disorders in two age-related groups. Drug therapy was analyzed to reveal potential cases of drug-drug interactions.Results. A total of 1 031 cases of the use of drug combinations leading to drug-drug interactions of various clinical significance were revealed in 72.4 % of patients. There were significant differences between two age-related groups in respect of the specifics of medications use and clinical significance of drug combinations.Conclusion. Prediction of drug-drug interactions is likely to ensure improved drug safety in patients with psychiatric disorders.

Keywords